TGFB1 and gastric cancer: In summary, elevated IL-10 and TGF-β1 levels in gastric cancer synergistically enhance immune checkpoint gene expression, including CD274 and CTLA4, thereby strengthening the immunosuppressive microenvironment and informing immune therapy resistance mechanisms and combined targeted strategies.